Home Cart Sign in  
Chemical Structure| 1428-67-7 Chemical Structure| 1428-67-7

Structure of DPN
CAS No.: 1428-67-7

Chemical Structure| 1428-67-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DPN is a non-steroidal estrogen receptor β (ER β) selective ligand.

Synonyms: Diarylpropionitrile; 2,3-bis (4-Hydroxyphenyl) Propionitrile

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DPN

CAS No. :1428-67-7
Formula : C15H13NO2
M.W : 239.27
SMILES Code : N#CC(C1=CC=C(O)C=C1)CC2=CC=C(O)C=C2
Synonyms :
Diarylpropionitrile; 2,3-bis (4-Hydroxyphenyl) Propionitrile
MDL No. :MFCD01695412

Safety of DPN

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H372-H410
Precautionary Statements:P501-P273-P260-P270-P264-P280-P391-P314-P337+P313-P305+P351+P338-P301+P312+P330
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HT-29 cells 0.3, 1, 3 µM 24 h To evaluate the effect of DPN on wound healing in colonic epithelial cells, results showed that DPN significantly promoted wound healing. PMC11873653
NCM460 cells 0.3, 1, 3 µM 24 h To evaluate the effect of DPN on wound healing in colonic epithelial cells, results showed that DPN significantly promoted wound healing. PMC11873653

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice DSS-induced colitis model Intraperitoneal injection 1, 2.5, 5 mg/kg Once daily for 5 consecutive days To evaluate the effect of DPN on colonic mucosal healing, results showed that DPN significantly promoted mucosal healing. PMC11873653
Male Sprague-Dawley rats Monocrotaline-induced pulmonary hypertension model Subcutaneous implantation 850 μg/kg Once daily for 10 days DPN was as effective as estrogen in reversing pulmonary hypertension, improving right ventricular function and structure PMC3208600
Mice WT and ARKO mice Injection 1 mg/kg Daily for one week DPN treatment protected WT and ARKO mice from acoustic trauma, reducing auditory threshold shifts PMC2260908
Female rats Ovariectomized rats Subcutaneous injection 20 μg/d 29 days To investigate the effects of DPN on the expression of neuroinflammatory genes in the frontal cortex of middle-aged female rats. Results showed that DPN modulated the expression of various neuroinflammatory genes, including up-regulation of defensins and down-regulation of complement C3 and its receptor Cd11b. PMC3161870
Mice Aromatase-knockout (ArKO) mice Subcutaneous injection 30 µg/animal (1 mg/kg body weight) Every 24 hours for 3 days To investigate the effect of DPN on GLUT4 expression, results showed that DPN significantly reduced GLUT4 expression on the cell membrane and in the cytosol PMC1360576
Mice Experimental autoimmune encephalomyelitis (EAE) model Subcutaneous injection 8 mg/kg Every 48 hours,Starting from day 0 post EAE induction until day 36–42 DPN treatment has neuroprotective effects by stimulating endogenous myelination, improving EAE clinical symptoms and remyelination PMC3839759
Sprague-Dawley rats Anesthetized rat model Bilateral microinjection into RVLM 1, 2 or 5 pmol Single injection, effects lasted for 3-4 hours To investigate the hypotensive effect of DPN via activation of ERβ in RVLM and the involvement of nongenomic activation of PI3K/Akt signaling pathway PMC3438069
Mice Experimental autoimmune encephalomyelitis (EAE) model Subcutaneous injection 8 mg/kg Every other day, until after EAE induction DPN upregulated the expression of cholesterol-synthesis pathway gene HMGCS1 and partially rescued the demyelination deficits in YAPGFAP-CKO EAE mice PMC8492624

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.18mL

0.84mL

0.42mL

20.90mL

4.18mL

2.09mL

41.79mL

8.36mL

4.18mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories